Diclofenac Sodium
Product Images NDC 61919-575

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 61919-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Directrx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Diclo575boxedwarning)

A text panel discussing cardiovascular thrombotic events and gastrointestinal risk associated with nonsteroidal anti-inflammatory drugs (NSAIDs). It highlights the increased risk of serious cardiovascular and gastrointestinal adverse events, including myocardial infarction, stroke, inflammation, bleeding, and ulceration. Specific contraindications for diclofenac sodium delayed-release tablets in coronary artery bypass graft surgery are noted, with references to warnings and precautions.*

FDA Label Image

Label (Diclofenacsodium575)

DICLOFENAC SODIUM D/R 50 mg, 60 tablets, packaging label from DirectRX. The label states it is a generic for Voltaren and contains enteric-coated tablets with Diclofenac Sodium USP 50 mg delayed-release. Includes barcode, lot number, discard date, and warnings about drowsiness or dizziness.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.